Vascular benefit of the use of mepivacaine as an anaesthetic in resilient hyaluronic acid® injectables
Year: 2025
Type: article
Abstract: Lidocaine (0.3% w/w) has long been used in HA-based injectables for pain relief, but mepivacaine may be a better alternative, offering similar efficacy without vasodilation, potentially lowering the risk of adverse events.
Source: RSC Pharmaceutics
DOI: 10.1039/d5pm00069f
Institutions: Teoxane SA (Switzerland), Revance (United States)
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4411207693